ArticleEuropean radiology2019

TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.

Roberto Iezzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.